{"id":"https://openalex.org/W4224081925","doi":"https://doi.org/10.3389/fimmu.2022.811867","title":"TNF-\u03b1-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy","display_name":"TNF-\u03b1-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy","publication_year":2022,"publication_date":"2022-04-14","ids":{"openalex":"https://openalex.org/W4224081925","doi":"https://doi.org/10.3389/fimmu.2022.811867","pmid":"https://pubmed.ncbi.nlm.nih.gov/35493461","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9046849"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2022.811867","doi":"https://doi.org/10.3389/fimmu.2022.811867","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.811867","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2022.811867/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2022.811867/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023513122","display_name":"Kirsten De Ridder","orcid":"https://orcid.org/0000-0003-1482-1742","observed_orcids":["https://orcid.org/0000-0003-1482-1742"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Kirsten De Ridder","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067448692","display_name":"Hanne Locy","orcid":"https://orcid.org/0000-0003-1832-0099","observed_orcids":["https://orcid.org/0000-0003-1832-0099"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Hanne Locy","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076885770","display_name":"Elisa Piccioni","orcid":"https://orcid.org/0000-0002-9995-3623","observed_orcids":["https://orcid.org/0000-0002-9995-3623"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Elisa Piccioni","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056720960","display_name":"Miren Zuazo","orcid":"https://orcid.org/0000-0001-8609-2089","observed_orcids":["https://orcid.org/0000-0001-8609-2089"]},"institutions":[{"id":"https://openalex.org/I4210117069","display_name":"Navarrabiomed","ror":"https://ror.org/03atdda90","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210117069"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miren Ibarra Zuazo","raw_affiliation_strings":["Immunomodulation Group, Navarrabiomed, Navarrabiomed-UPNA-IdISNA, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunomodulation Group, Navarrabiomed, Navarrabiomed-UPNA-IdISNA, Pamplona, Spain","institution_ids":["https://openalex.org/I4210117069"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011563852","display_name":"Robin Maximilian Awad","orcid":"https://orcid.org/0000-0001-5434-494X","observed_orcids":["https://orcid.org/0000-0001-5434-494X"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Robin Maximilian Awad","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058411613","display_name":"Stefaan Verhulst","orcid":"https://orcid.org/0000-0001-6566-6071","observed_orcids":["https://orcid.org/0000-0001-6566-6071","https://orcid.org/0000-0002-0107-2984"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Stefaan Verhulst","raw_affiliation_strings":["Liver Cell Biology Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Cell Biology Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029428843","display_name":"Mathias Van Bulck","orcid":"https://orcid.org/0000-0002-5129-8092","observed_orcids":["https://orcid.org/0000-0002-5129-8092"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Mathias Van Bulck","raw_affiliation_strings":["Laboratory of Molecular and Medical Oncology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular and Medical Oncology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073798404","display_name":"Yannick De Vlaeminck","orcid":"https://orcid.org/0000-0002-1882-4740","observed_orcids":["https://orcid.org/0000-0002-1882-4740"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Yannick De Vlaeminck","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090222753","display_name":"Quentin Lecocq","orcid":"https://orcid.org/0000-0002-2627-0880","observed_orcids":["https://orcid.org/0000-0002-2627-0880"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Quentin Lecocq","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011645172","display_name":"Eva Reijmen","orcid":"https://orcid.org/0000-0003-3996-9188","observed_orcids":["https://orcid.org/0000-0003-3996-9188"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Eva Reijmen","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018512200","display_name":"Wout de Mey","orcid":"https://orcid.org/0000-0002-5747-101X","observed_orcids":["https://orcid.org/0000-0002-5747-101X"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Wout De Mey","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069212985","display_name":"Lien De Beck","orcid":"https://orcid.org/0000-0002-8445-0441","observed_orcids":["https://orcid.org/0000-0002-8445-0441"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Lien De Beck","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005817853","display_name":"Thomas Ertveldt","orcid":"https://orcid.org/0000-0001-7825-7808","observed_orcids":["https://orcid.org/0000-0001-7825-7808"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Thomas Ertveldt","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008950728","display_name":"Isabel Pintelon","orcid":"https://orcid.org/0000-0003-2901-4679","observed_orcids":["https://orcid.org/0000-0003-2901-4679"]},"institutions":[{"id":"https://openalex.org/I149213910","display_name":"University of Antwerp","ror":"https://ror.org/008x57b05","country_code":"BE","type":"education","lineage":["https://openalex.org/I149213910"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Isabel Pintelon","raw_affiliation_strings":["Laboratory of Cell Biology & Histology, Antwerp Centre for Advanced Microscopy (ACAM), University of Antwerp, Antwerp, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology & Histology, Antwerp Centre for Advanced Microscopy (ACAM), University of Antwerp, Antwerp, Belgium","institution_ids":["https://openalex.org/I149213910"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085832818","display_name":"Jean\u2010Pierre Timmermans","orcid":"https://orcid.org/0000-0003-2506-6252","observed_orcids":["https://orcid.org/0000-0003-2506-6252"]},"institutions":[{"id":"https://openalex.org/I149213910","display_name":"University of Antwerp","ror":"https://ror.org/008x57b05","country_code":"BE","type":"education","lineage":["https://openalex.org/I149213910"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jean-Pierre Timmermans","raw_affiliation_strings":["Laboratory of Cell Biology & Histology, Antwerp Centre for Advanced Microscopy (ACAM), University of Antwerp, Antwerp, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology & Histology, Antwerp Centre for Advanced Microscopy (ACAM), University of Antwerp, Antwerp, Belgium","institution_ids":["https://openalex.org/I149213910"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091638762","display_name":"David Escors","orcid":"https://orcid.org/0000-0003-2828-4458","observed_orcids":["https://orcid.org/0000-0003-2828-4458"]},"institutions":[{"id":"https://openalex.org/I4210117069","display_name":"Navarrabiomed","ror":"https://ror.org/03atdda90","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210117069"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["ES","GB"],"is_corresponding":false,"raw_author_name":"David Escors","raw_affiliation_strings":["Immunomodulation Group, Navarrabiomed, Navarrabiomed-UPNA-IdISNA, Pamplona, Spain","Rayne Institute, Division of Infection and Immunity, University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunomodulation Group, Navarrabiomed, Navarrabiomed-UPNA-IdISNA, Pamplona, Spain","institution_ids":["https://openalex.org/I4210117069"]},{"raw_affiliation_string":"Rayne Institute, Division of Infection and Immunity, University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038137427","display_name":"Marleen Keyaerts","orcid":"https://orcid.org/0000-0002-9997-4571","observed_orcids":["https://orcid.org/0000-0002-9997-4571"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Marleen Keyaerts","raw_affiliation_strings":["In Vivo Cellular and Molecular Imaging laboratory, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"In Vivo Cellular and Molecular Imaging laboratory, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048780479","display_name":"Karine Breckpot","orcid":"https://orcid.org/0000-0003-4331-3480","observed_orcids":["https://orcid.org/0000-0003-4331-3480"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Karine Breckpot","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045954244","display_name":"Cleo Goyvaerts","orcid":"https://orcid.org/0000-0002-1725-7772","observed_orcids":["https://orcid.org/0000-0002-1725-7772"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Cleo Goyvaerts","raw_affiliation_strings":["Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5045954244"],"corresponding_institution_ids":["https://openalex.org/I13469542"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.9692,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.88718025,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"13","issue":null,"first_page":"811867","last_page":"811867"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.0272000003606081,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8700000047683716},{"id":"https://openalex.org/keywords/tumor-infiltrating-monocytes","display_name":"tumor-infiltrating monocytes","score":0.9810000061988831},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.9570000171661377},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.8820000290870667},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9610000252723694},{"id":"https://openalex.org/keywords/lewis-lung-carcinoma","display_name":"Lewis lung carcinoma","score":0.8759999871253967},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8230000138282776},{"id":"https://openalex.org/keywords/myeloid-cells","display_name":"myeloid cells","score":0.675000011920929},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.7400000095367432},{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.7699999809265137},{"id":"https://openalex.org/keywords/sirpalpha","display_name":"SIRP\u03b1","score":0.9950000047683716},{"id":"https://openalex.org/keywords/vista","display_name":"VISTA","score":0.6700000166893005},{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.8629999756813049},{"id":"https://openalex.org/keywords/cd80","display_name":"CD80","score":0.9010000228881836},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.5730000138282776},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7555258274078369},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6195645928382874},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5806135535240173},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5512446761131287},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.5264716148376465},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.4552014470100403},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.41816315054893494},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38462162017822266},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23933947086334229},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12956511974334717}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.3389/fimmu.2022.811867","doi":"https://doi.org/10.3389/fimmu.2022.811867","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.811867","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2022.811867/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9046849","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9046849","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:35493461","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35493461","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:academica-e.unavarra.es:2454/43383","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2454/43383","pdf_url":"https://academica-e.unavarra.es/bitstreams/e45d550a-d302-43d6-9b3e-2df8a8c72484/download","source":{"id":"https://openalex.org/S4306402560","display_name":"Academica-e (Universidad P\u00fablica de Navarra)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I175051016","host_organization_name":"Universidad P\u00fablica de Navarra (UPNA)","host_organization_lineage":["https://openalex.org/I175051016"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:8cb0f64de304414d9efd07fa0701e7a3","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/8cb0f64de304414d9efd07fa0701e7a3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 13 (2022)","raw_type":"article"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:160112","doi":null,"is_oa":false,"landing_page_url":"https://biblio.vub.ac.be/vubir/tnf\u03b1secreting-lung-tumorinfiltrated-monocytes-play-a-pivotal-role-during-antipdl1-immunotherapy(de86c924-5eba-46fa-a377-b2bfc72fcdbe).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:164665","doi":null,"is_oa":false,"landing_page_url":"https://biblio.vub.ac.be/vubir/tnf\u03b1secreting-lung-tumorinfiltrated-monocytes-play-a-pivotal-role-for-effective-antipdl1-immunotherapy(3f000dbc-b0db-4222-9701-d05f0bb6fbaa).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2022.811867","doi":"https://doi.org/10.3389/fimmu.2022.811867","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.811867","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2022.811867/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1859101464","display_name":null,"funder_award_id":"BMED 050-2019","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G202520303","display_name":"Desarrollo de nuevos linfocitos T y CAR antineopl\u00e1sicos para terapias de transferencia celular","funder_award_id":"PI20/00010","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G2166367319","display_name":"Target and explore the \u2018X factor\u2019 of the lung tumor microenvironment.","funder_award_id":"1515718N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"},{"id":"https://openalex.org/G3583203363","display_name":null,"funder_award_id":"BMED 050-2019","funder_id":"https://openalex.org/F4320329682","funder_display_name":"Gobierno de Navarra"},{"id":"https://openalex.org/G3908652900","display_name":null,"funder_award_id":"S004317N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"},{"id":"https://openalex.org/G5960052704","display_name":"Impacto de la inmunoterapia anti-PDL1/PD1 sobre las capacidades anti-tumorales de los linfocitos T humanos en diferentes estad\u00edos de diferenciaci\u00f3n","funder_award_id":"PI17/02119","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G6288421493","display_name":null,"funder_award_id":"1515718N , S004317N, G041721N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"},{"id":"https://openalex.org/G6671644224","display_name":null,"funder_award_id":"FEDER-PI17/02119, FEDER-PI20/00010","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G6750604453","display_name":null,"funder_award_id":"PROYE16001ESCO","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G6948362326","display_name":null,"funder_award_id":"FEDER-PI20/00010","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G8172865061","display_name":null,"funder_award_id":"PROYE16001ESCO","funder_id":"https://openalex.org/F4320321411","funder_display_name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer"},{"id":"https://openalex.org/G8469398021","display_name":null,"funder_award_id":"PROYE16001ESCO","funder_id":"https://openalex.org/F4320329682","funder_display_name":"Gobierno de Navarra"},{"id":"https://openalex.org/G8989350006","display_name":"Creation of a 3D CRiMe scene to unravel Cytotoxicity Resistant Mechanisms in non-small cell lung cancer.","funder_award_id":"G041721N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"},{"id":"https://openalex.org/G964370150","display_name":null,"funder_award_id":"FEDER-PI17/02119","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"}],"funders":[{"id":"https://openalex.org/F4320321411","display_name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","ror":"https://ror.org/00gxct719"},{"id":"https://openalex.org/F4320321730","display_name":"Fonds Wetenschappelijk Onderzoek","ror":"https://ror.org/03qtxy027"},{"id":"https://openalex.org/F4320322634","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04"},{"id":"https://openalex.org/F4320324595","display_name":"Universiteit Antwerpen","ror":"https://ror.org/008x57b05"},{"id":"https://openalex.org/F4320327317","display_name":"Kom op tegen Kanker","ror":null},{"id":"https://openalex.org/F4320327336","display_name":"Vlaamse regering","ror":null},{"id":"https://openalex.org/F4320329682","display_name":"Gobierno de Navarra","ror":"https://ror.org/025qq4838"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4224081925.pdf","grobid_xml":"https://content.openalex.org/works/W4224081925.grobid-xml"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W1542147641","https://openalex.org/W2146073081","https://openalex.org/W2159803625","https://openalex.org/W2329974159","https://openalex.org/W2472917228","https://openalex.org/W2584487585","https://openalex.org/W2586893766","https://openalex.org/W2589277622","https://openalex.org/W2599186163","https://openalex.org/W2599666089","https://openalex.org/W2611596972","https://openalex.org/W2612649234","https://openalex.org/W2615301036","https://openalex.org/W2745683917","https://openalex.org/W2750364489","https://openalex.org/W2756272479","https://openalex.org/W2779658193","https://openalex.org/W2782998220","https://openalex.org/W2783246934","https://openalex.org/W2796439452","https://openalex.org/W2808030800","https://openalex.org/W2865352686","https://openalex.org/W2883594834","https://openalex.org/W2895245013","https://openalex.org/W2897460617","https://openalex.org/W2901870130","https://openalex.org/W2904211489","https://openalex.org/W2908456822","https://openalex.org/W2911604706","https://openalex.org/W2921760704","https://openalex.org/W2929034286","https://openalex.org/W2942744719","https://openalex.org/W2942834448","https://openalex.org/W2943218134","https://openalex.org/W2951492084","https://openalex.org/W2972425427","https://openalex.org/W2974856095","https://openalex.org/W2980933209","https://openalex.org/W2982633192","https://openalex.org/W2986360475","https://openalex.org/W2997277554","https://openalex.org/W2999694070","https://openalex.org/W3010741030","https://openalex.org/W3018124344","https://openalex.org/W3026270374","https://openalex.org/W3032582223","https://openalex.org/W3049216986","https://openalex.org/W3083415390","https://openalex.org/W3093185007","https://openalex.org/W3110311384","https://openalex.org/W3136393438","https://openalex.org/W3152722946","https://openalex.org/W3155034149","https://openalex.org/W3196113187","https://openalex.org/W3202940562","https://openalex.org/W6769897288"],"related_works":["https://openalex.org/W4226375877","https://openalex.org/W4382400160","https://openalex.org/W4388047787","https://openalex.org/W4230752110","https://openalex.org/W4409884233","https://openalex.org/W3085714880","https://openalex.org/W4362592200","https://openalex.org/W3018348882","https://openalex.org/W3193746213","https://openalex.org/W4303414931"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1],"blockade":[2],"(ICB)":[3],"of":[4,22,85,93,126,135,201],"the":[5,9,20,38,47,54,152,171,198],"PD-1":[6],"pathway":[7],"revolutionized":[8],"survival":[10],"forecast":[11],"for":[12,37],"advanced":[13],"non-small":[14],"cell":[15],"lung":[16,55,97,202],"cancer":[17],"(NSCLC).":[18],"Yet,":[19],"majority":[21],"PD-L1+":[23,39],"NSCLC":[24],"patients":[25],"are":[26],"refractory":[27],"to":[28,67,76,118,177,205],"anti-PD-L1":[29,77,109,163],"therapy.":[30,78],"Recent":[31],"observations":[32],"indicate":[33],"a":[34,50,112,159],"pivotal":[35],"role":[36,161],"tumor-infiltrating":[40,86],"myeloid":[41,72],"cells":[42],"in":[43,53,74,96,103,106,162,184],"therapy":[44,110],"failure.":[45],"As":[46],"latter":[48],"comprise":[49],"heterogenous":[51],"population":[52],"tumor":[56,143],"microenvironment,":[57],"we":[58,80,101],"applied":[59],"an":[60],"orthotopic":[61],"Lewis":[62],"Lung":[63],"Carcinoma":[64],"(LLC)":[65],"model":[66],"evaluate":[68],"11":[69],"different":[70],"tumor-residing":[71],"subsets":[73],"response":[75,117],"While":[79],"observed":[81],"significantly":[82],"reduced":[83],"fractions":[84],"MHC-IIlow":[87],"macrophages":[88],"and":[89,105,116,131,137,156],"monocytes,":[90],"serological":[91],"levels":[92],"TNF-\u03b1":[94,138,157],"restored":[95],"tumor-bearing":[98],"mice.":[99],"Notably,":[100],"demonstrated":[102],"vivo":[104],"vitro":[107,185],"that":[108,147,154,173],"mediated":[111],"monocyte-specific":[113],"production":[114],"of,":[115],"TNF-\u03b1,":[119],"further":[120],"accompanied":[121],"by":[122,151,170],"their":[123],"significant":[124],"upregulation":[125],"CD80,":[127],"VISTA,":[128],"LAG-3,":[129],"SIRP-\u03b1":[130,192],"TIM-3.":[132],"Nevertheless,":[133],"co-blockade":[134],"PD-L1":[136,188],"did":[139],"not":[140],"reduce":[141],"LLC":[142,182],"growth.":[144],"A":[145],"phenomenon":[146],"was":[148,168],"partly":[149],"explained":[150],"observation":[153,172],"monocytes":[155,174,204],"play":[158],"Janus-faced":[160],"therapy-mediated":[164],"CTL":[165],"stimulation.":[166],"This":[167],"endorsed":[169],"appeared":[175],"crucial":[176],"effectively":[178],"boost":[179],"T":[180],"cell-mediated":[181],"killing":[183],"upon":[186],"combined":[187],"with":[189],"LAG-3":[190],"or":[191],"blockade.":[193],"Hence,":[194],"this":[195],"study":[196],"enlightens":[197],"biomarker":[199],"potential":[200],"tumor-infiltrated":[203],"define":[206],"more":[207],"effective":[208],"ICB":[209],"combination":[210],"strategies.":[211]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-04-19T00:00:00"}